- Home
- HHS vs BRNS Comparison
HHS vs BRNS Comparison
Compare HHS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- BRNS
- Stock Information
- Founded
- HHS 1923
- BRNS 2016
- Country
- HHS United States
- BRNS United Kingdom
- Employees
- HHS N/A
- BRNS N/A
- Industry
- HHS Advertising
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- HHS Consumer Discretionary
- BRNS Health Care
- Exchange
- HHS Nasdaq
- BRNS Nasdaq
- Market Cap
- HHS 55.0M
- BRNS 52.0M
- IPO Year
- HHS N/A
- BRNS 2021
- Fundamental
- Price
- HHS $7.45
- BRNS $1.17
- Analyst Decision
- HHS
- BRNS Strong Buy
- Analyst Count
- HHS 0
- BRNS 2
- Target Price
- HHS N/A
- BRNS $4.00
- AVG Volume (30 Days)
- HHS 14.9K
- BRNS 38.8K
- Earning Date
- HHS 11-07-2024
- BRNS 11-07-2024
- Dividend Yield
- HHS N/A
- BRNS N/A
- EPS Growth
- HHS N/A
- BRNS N/A
- EPS
- HHS N/A
- BRNS N/A
- Revenue
- HHS $187,093,000.00
- BRNS N/A
- Revenue This Year
- HHS N/A
- BRNS $27.18
- Revenue Next Year
- HHS $4.05
- BRNS N/A
- P/E Ratio
- HHS N/A
- BRNS N/A
- Revenue Growth
- HHS N/A
- BRNS N/A
- 52 Week Low
- HHS $5.50
- BRNS $1.11
- 52 Week High
- HHS $8.87
- BRNS $5.10
- Technical
- Relative Strength Index (RSI)
- HHS 50.77
- BRNS 40.45
- Support Level
- HHS $6.66
- BRNS $1.15
- Resistance Level
- HHS $7.47
- BRNS $1.35
- Average True Range (ATR)
- HHS 0.27
- BRNS 0.07
- MACD
- HHS 0.01
- BRNS 0.00
- Stochastic Oscillator
- HHS 77.45
- BRNS 14.29
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.